Market Research Report
Global Proteomics Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
|Published by||Occams Business Research & Consulting Pvt. Ltd.||Product code||357453|
|Published||Content info||140 Pages
Delivery time: Inquiry
|Global Proteomics Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022|
|Published: June 12, 2016||Content info: 140 Pages||
The global proteomics market is estimated to register robust growth during 2016- 2022 and is expected to grow at CAGR of 16.35% during the forecasted period. The proteomics market is segmented on the basis of technology, reagents, services, application and geography. The technology segment is segmented into protein microarray, spectroscopy, x-ray crystallography chromatography, electrophoresis, surface plasmon resonance (spr) systems, protein fractionation systems. The protein microarray is further segmented into biochips, microarray instruments. The spectroscopy segment is divided into mass spectroscopy, NMR spectroscopy, circular dichroism (cd) spectroscopy. The chromatography is further segmented into ion chromatography, supercritical fluid chromatography, HPLC systems, affinity chromatography. Electrophoresis is further segmented into gel electrophoresis, capillary electrophoresis. The reagents segment is segmented into microarray reagent, spectroscopy reagent, x-ray crystallography reagent, chromatography reagents, electrophoresis reagents, immunoassay reagents, protein fractionation reagents. The services are segmented into analytical laboratory services, data analysis & maintenance. The analytical laboratory services are segmented into protein identification, protein separation, protein sequencing. The data analysis & maintenance is segmented into bioinformatics databases, bioinformatics tools. However, the application segment is segmented into drug discovery, clinical diagnosis, others.
The increased funding by government and private firms in research and development and increased demand for personalized medicine is increasing the growth in the global proteomics market. The high elderly population, prevalence of lifestyle diseases, technological advancements are boosting the global market of proteomics.
Various key players are indulging in various research and development activity to develop new chemicals so as to enhance efficiency & to capture the market potential available in the emerging economies. Various key players are adopting the strategic moves to maintain position in the global proteomics market. Abbott Laboratories, Bausch & Lomb, Fresenius Medical Care AG & Co. KGAA, General Electric Co., Johnson & Johnson Inc. (U.S), Medtronic Inc., Philips Healthcare, Roche Diagnostics Limited, Siemens AG.
The proteomics market is majorly driven by increased demand for personalized medicine which is increasing the scope of proteomics in global market. However, the expensive tools & equipment's and weak research and development in emerging markets are hampering the growth of the global market. The reduction in funds by the US government, which owes 40% of this market and highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the market and research are the major restraints available in the market. The rising demand from emerging countries are increasing the scope of proteomics and creating huge opportunities in the global market.
On the basis of geography, North America, Europe, Asia Pacific and ROW are the major segments. North America hold the largest markets share followed by Europe, Asia Pacific and ROW in the global proteomics market. In 2014, North America market share was accounted at 41% of the global market. The growth in the region is majorly driven by increasing growth in research and development expenditure in biotechnology and pharmaceutical industry, rising technological advancements to enhance the sensitivity and high resolution in proteomics.